Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-11 4:40 pm Unchanged | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 24,724,468 39.7% | 0 (Unchanged) | View |
| 2023-07-25 4:19 pm Purchase | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 24,724,468 39.8% | 1,735,988 (+7.55%) | View |
| 2022-06-03 4:30 pm Purchase | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 22,988,480 40.4% | 22,988,480 (New Position) | View |
| 2021-11-08 06:15 am Purchase | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 22,988,480 45.8% | 1,812,500 (+8.56%) | View |
| 2020-07-21 4:45 pm Unchanged | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 21,175,980 60.3% | 0 (Unchanged) | View |
| 2020-03-13 5:01 pm Purchase | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 21,175,980 60.2% | 21,175,980 (New Position) | View |